Medicine and Dentistry
Congestive Heart Failure
100%
Meta-Analysis
69%
Systematic Review
69%
Geriatrics
69%
Long-Term Care
69%
Brain Natriuretic Peptide
63%
Diseases
53%
Diagnosis
52%
Placebo
52%
Prevalence
47%
Implantable Automatic Defibrillator
41%
Pulmonary Hypertension
39%
Cohort Effect
34%
Acute Heart Infarction
34%
Empagliflozin
34%
Atrial Fibrillation
34%
Paracoccidioidomycosis
34%
Natriuretic Factor
34%
Hyperkalemia
34%
Percutaneous Aortic Valve Replacement
34%
Cardiac Fibrosis
34%
Arteriosclerosis Obliterans
34%
Eisenmenger's Syndrome
34%
Heart Transplantation
34%
Endothelial Function
34%
Aortic Valve Stenosis
34%
Polyunsaturated Fatty Acid
34%
Defibrillator
34%
R Wave
34%
Nurse
34%
Kaplan Meier Method
34%
Venous Thromboembolism
34%
Amino Terminal Sequence
28%
Hormone Precursor
28%
Cardiovascular System
23%
Aortic Valve Replacement
21%
Patiromer
20%
Sodium Zirconium Cyclosilicate
20%
Renin Angiotensin Aldosterone System
20%
Iodinated Contrast Medium
19%
All Cause Mortality
19%
Shock (Circulatory)
18%
End-Diastolic Volume
16%
Omega-3 Fatty Acid
13%
Vasodilatation
13%
Systemic Mycosis
13%
Apoplexy
13%
Antithrombotic
13%
Cumulative Incidence
12%
Cardiovascular Disease
11%
Pharmacology, Toxicology and Pharmaceutical Science
Empagliflozin
55%
Sodium Glucose Cotransporter 2 Inhibitor
39%
Myocarditis
34%
Venous Thromboembolism
34%
Prevalence
34%
Virus Infection
34%
Pulmonary Hypertension
34%
Mycosis
34%
South American Blastomycosis
34%
Low Density Lipoprotein Cholesterol
34%
Ertugliflozin
34%
Hospital Mortality
34%
Acute Heart Infarction
34%
High Density Lipoprotein
34%
Clusterin
34%
Placebo
34%
Peripheral Occlusive Artery Disease
34%
Hormone Precursor
28%
Omega-3 Fatty Acid
22%
Aortic Regurgitation
17%
Systemic Mycosis
13%
Cardiovascular Risk
10%
Sodium Glucose Cotransporter 2
9%
Chronic Thromboembolic Pulmonary Hypertension
9%
Placebo-Controlled Study
8%
Fusarium
6%
Beta Adrenergic Receptor Blocking Agent
6%
Non Insulin Dependent Diabetes Mellitus
6%
Adverse Event
6%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Cohort Study
6%
Congestive Heart Failure
6%
Creatine Kinase
5%
